Critically, this action is glucose-dependent, meaning it reduces the risk of hypoglycemia (low blood sugar) when glucose levels are normal
Semaglutide (Wegovy/Ozempic) is a breakthrough obesity treatment offering sustainable, clinically significant weight loss with additional metabolic benefits
Although current studies report that a variety of nanocarriers, including liposome-based nanoparticles, micelles-based nanoparticles, inorganic nanoparticles, hydrogel nanoparticles, and orther novel nanoparticles, can all achieve lymph node targeting, and each carrier has its unique advantages
It functions by replicating a naturally occurring hormone (GLP-1) that helps control appetite, resulting in decreased food consumption and subsequent weight reduction
Your healthcare provider will check how your body responds to treatment
Instead, hormone signals gradually return to baseline over 6 weeks